Medical Marijuana Inc (OTCMKTS: MJNA) recently announced that its subsidiary Kannaway recently opened a warehouse and new offices in Warsaw, Poland. As a result, medical Marijuana, Inc...
Medical Marijuana Inc. (OTCMKTS:MJNA) has announced that its Banned Substances Control Group (BSCG) has awarded its subsidiary Kannaway® Certified Drug-Free approval broad-spectrum cannabidiol product Pure Gold....
Medical Marijuana Inc (OTCMKTS:MJNA) released its financial results for the quarter ending September 30, 2020. It has also used the opportunity to give its most recent...
Kannalife Inc (OTCMKTS:KLFE) obtained additional patents for its patent – WO2015/106108A2 in 12 key nations that include the Netherlands, Turkey, Sweden, Spain, Ireland, the UK, France,...
Axim Biotechnologies Inc. (OTCMKTS:AXIM), an investment company of Medical Marijuana Inc. (OTCMKTS:MJNA), has announced the expansion of its research division by establishing an ultra-modern laboratory in...
Medical Marijuana Inc (OTCMKTS:MJNA) has posted revenues of $75.6 million in 2019. It is an increase of 26.3% when compared to 2018. The adjusted EBITDA has...
Kannalife Inc (OTCMKTS:KLFE), a portfolio company of Medical Marijuana Inc (OTCMKTS:MJNA), has received an Australian patent No. AU2015204609B2, which is specific to the Novel Functionalized 1,3-Benzene...
Kannalife, Inc, a portfolio investment company of Medical Marijuana Inc (OTCMKTS:MJNA), has completed the phase 1 study of its patented CBD like module – KLS-13019 to...
HempMeds Mexico, a subsidiary of Medical Marijuana Inc (OTCMKTS:MJNA), has inaugurated Mexico City Office. President of HempMeds Latin America and Mexico, Raul Elizalde, said the company...
Medical Marijuana Inc (OTCMKTS:MJNA) is quite pleased about the recent development of its best-performing subsidiary HempMeds®. This subsidiary has just found its way into the Leafly...